Contraception

The survey highlighted increased services through primary care and in rural areas, and also emphasized a need for more providers to ensure equitable access.

Women with higher body mass indexes (BMI) and weights are significantly more likely to experience failure with levonorgestrel as emergency contraception than women with lower BMIs and weights.

Community perspectives on pharmacist-prescribed hormonal contraception in rural California reveal that awareness among potential users is low, despite people being supportive and interested in the service.

Lois McGuire, MSN, APRN, WHNP-BC, NCMP, shared her expertise in perimenopausal contraception during the Nurse Practitioners in Women’s Health (NPWH) 25th Annual Premier Women’s Health Conference, held in Houston, Texas from September 28 to October 2, 2022.

Practicing clinicians were highly impressed with an interactive, virtual intrauterine device (IUD) training model that increased their comfort with IUD placement and removal, according to a study published in the journal Family Medicine.

A systematic review on measuring unmet need in sexual and reproductive health has concluded that the emphasis is on contraception for women in low-income countries, while unmet need for sexual health in general, especially among men, and unmet reproductive health need in high-income settings lack much evidence.

In a recent study, it was found that access to contraceptive services declined during the COVID-19 pandemic.

Nearly half (45%) of all pregnancies in the United States from 2015 to 2019 were unintended.

Consider the needs of marginalized patients to promote equity

After a recent FDA approval, Mirena can be used to prevent pregnancy for up to 8 years.

Best practices on discussing birth control for adolescents.

State regulations overruled to protect physicians’ clinical judgments.

Perrigo’s HRA Pharma has submitted an application to the US Food and Drug Administration (FDA) for possible future approval of the first-ever OTC birth control pill.

US President Joe Biden signed an executive order Friday protecting nationwide access to abortion and contraception.

As we were going to press with the July issue, the United States Supreme Court overturned Roe v Wade, eliminating the constitutional right to an abortion, and leaving the question of abortion rights to the states.

Bethany Corbin, Esq., sits down with Contemporary OB/GYN® to discuss the recent Supreme Court ruling overturning Roe v Wade and striking down almost 50 years of abortion precedent.

The United States Supreme Court voted to overturn Roe v Wade on Friday, eliminating the constitutional right to an abortion, and leaving the question of abortion rights to the states.

Interviews with mothers in the immediate postpartum period revealed that most decisions on breastfeeding and contraception were based on the personal experiences of participants and their friends and family.

Bassem Maximos, MD, MPH, FACOG, discusses 2 recent studies investigating nonhormomal contraceptive gel Phexxi (Evofem Biosciences) for the potential treatment of UTIs and improvement in sexual satisfaction.

A recent study presented at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting found that there was neither a decreased nor increased risk for postpartum depression in patients who received hormonal contraception due to insufficient evidence.

Elizabeth Ruzzo, PhD, discusses the findings of a report published by the UNFPA, which found women were abandoning effective methods of contraception due to misinformation.

Helen C. Wang, MD, shares key takeaways from the session she co-presented at PAS 2022.

TikTok user @midwifemama sparked a conversation about IUD insertion.

A cohort study in JAMA Pediatrics indicates that policies that increase access to immediate postpartum long-acting reversible contraception (LARC) improve birth outcomes.

Contraceptive effectiveness is determined by several factors, including drug or device efficacy, individual fecundability, coital frequency, and user adherence and continuation.

While the use of combined oral contraceptives (COCs) among patients with rheumatoid and autoimmune disorders have focused on safety, a narrative review in the Journal of Obstetrics and Gynaecology Research highlighted the efficacy and benefits of these contraceptives in females with rheumatoid arthritis (RA).

Combined oral contraceptives were found to be moderately more efficacious than placebo for treating overall premenstrual symptomatology in women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD).

Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.

Agile Therapeutics, Inc. recently announced a new alliance with Afaxys Pharma, LLC to promote levonorgestrel and ethinyl estradiol (Twirla) transdermal system.